Related Experiment Videos
Ruthenium (II) nitrofurylsemicarbazone complexes: new DNA binding agents
Eliana Cabrera1, Hugo Cerecetto, Mercedes González
1Departamento de Química Orgánica, Facultad de Química-Facultad de Ciencias, Universidad de la República, Iguá 4225, 11400 Montevideo, Uruguay.
European Journal of Medicinal Chemistry
|April 10, 2004
Summary
Ruthenium(II) complexes with 5-nitrofurylsemicarbazone ligands show excellent DNA binding but lack anti-tumor activity due to high hydrophilicity, compromising their lipophilic properties and cellular uptake.
Area of Science:
- Coordination Chemistry
- Medicinal Chemistry
- Biochemistry
Background:
- Ruthenium complexes are explored for anti-tumor properties.
- 5-nitrofurylsemicarbazone derivatives possess potential anti-tumor activity.
- Combining metal centers with bioactive ligands can yield synergistic effects.
Purpose of the Study:
- Synthesize and characterize novel Ruthenium(II) complexes with 5-nitrofurylsemicarbazone ligands.
- Evaluate the DNA binding affinity of these new complexes.
- Assess the in vitro anti-tumor activity and investigate the factors influencing cellular cytotoxicity.
Main Methods:
- Synthesis of [Ru(II)Cl(2)(DMSO)(2)L] complexes.
- DNA binding studies using calf thymus DNA.
- In vitro cytotoxicity assays under aerobic and bio-reductive conditions.
- Analysis of redox behavior, lipophilicity, and stability.
Main Results:
- The synthesized Ruthenium(II) complexes exhibit strong binding to calf thymus DNA.
- Complexes demonstrated no significant cytotoxicity against tested tumor cell lines.
- Lipophilicity studies revealed the complexes are 10-100 times more hydrophilic than parent ligands.
Conclusions:
- The synthesized Ruthenium(II) complexes are effective DNA binders.
- Lack of anti-tumor activity is attributed to poor lipophilicity and consequently inadequate cellular uptake.
- Further modifications are needed to enhance lipophilicity for improved bio-activity.